We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+11.3%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$52.3B
AUM Growth
+$4.34B
(+9%)
Cap. Flow
-$146M
Cap. Flow
% of AUM
-0.28%
Top 10 Holdings %
Top 10 Hldgs %
26.12%
Holding
2,277
New
427
Increased
521
Reduced
1,052
Closed
79
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IS
ironSource Ltd.
IS
|
+$136M |
| 2 |
Tesla
TSLA
|
+$119M |
| 3 |
Verizon
VZ
|
+$109M |
| 4 |
Home Depot
HD
|
+$101M |
| 5 |
Pfizer
PFE
|
+$88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$247M |
| 2 |
Intel
INTC
|
+$216M |
| 3 |
Ford
F
|
+$145M |
| 4 |
General Motors
GM
|
+$143M |
| 5 |
Micron Technology
MU
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.15% |
| 2 | Healthcare | 14.97% |
| 3 | Financials | 14.22% |
| 4 | Consumer Discretionary | 11.15% |
| 5 | Communication Services | 8.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSII
1776
DELISTED
Cardiovascular Systems, Inc.
CSII
| $334K | ﹤0.01% |
17,800
-11,000
| -38% | -$294K |
|
|
VISN
1777
Vistance Networks Inc
VISN
$2.67B
| $333K | ﹤0.01% |
30,150
+11,715
| +64% | +$128K |
|
1778
Universal Insurance Holdings
UVE
$1.23B
| $332K | ﹤0.01% |
19,549
-9,950
| -34% | -$150K |
|
1779
Grid Dynamics Holdings
GDYN
$513M
| $331K | ﹤0.01% |
+8,730
| New | +$302K |
|
1780
GDS Holdings
GDS
$6.14B
| $330K | ﹤0.01% |
7,000
| – | – |
|
1781
DMC Global
BOOM
$112M
| $329K | ﹤0.01% |
8,310
-17,190
| -67% | -$685K |
|
1782
Southside Bancshares
SBSI
$974M
| $329K | ﹤0.01% |
7,860
-8,240
| -51% | -$341K |
|
1783
C3.ai
AI
$1.38B
| $328K | ﹤0.01% |
+10,510
| New | +$426K |
|
|
AAN
1784
DELISTED
The Aaron's Company Inc
AAN
| $328K | ﹤0.01% |
13,322
-13,280
| -50% | -$339K |
|
|
DBD
1785
DELISTED
Diebold Nixdorf Incorporated
DBD
| $325K | ﹤0.01% |
35,920
-21,380
| -37% | -$199K |
|
1786
Clover Health Investments
CLOV
$2.28B
| $324K | ﹤0.01% |
+87,110
| New | +$534K |
|
1787
Sinclair Inc
SBGI
$1.02B
| $323K | ﹤0.01% |
+12,210
| New | +$326K |
|
1788
Quanex
NX
$893M
| $322K | ﹤0.01% |
13,014
-16,170
| -55% | -$361K |
|
1789
CAE Inc. Common Shares
CAE
$8.48B
| $321K | ﹤0.01% |
12,704
| – | – |
|
1790
ChargePoint
CHPT
$138M
| $321K | ﹤0.01% |
844
-8,093
| -91% | -$3.59M |
|
1791
Coherus Oncology
CHRS
$222M
| $321K | ﹤0.01% |
20,100
| – | – |
|
1792
Phreesia
PHR
$671M
| $321K | ﹤0.01% |
+7,700
| New | +$457K |
|
|
NTUS
1793
DELISTED
Natus Medical Inc
NTUS
| $320K | ﹤0.01% |
13,487
-12,850
| -49% | -$317K |
|
|
AXNX
1794
DELISTED
Axonics, Inc. Common Stock
AXNX
| $319K | ﹤0.01% |
+5,690
| New | +$348K |
|
1795
Inogen
INGN
$174M
| $317K | ﹤0.01% |
9,315
-6,120
| -40% | -$222K |
|
1796
Harmonic Inc
HLIT
$1.2B
| $316K | ﹤0.01% |
26,900
| – | – |
|
1797
ICL Group
ICL
$6.76B
| $316K | ﹤0.01% |
32,815
+11,900
| +57% | +$106K |
|
1798
Scholar Rock
SRRK
$5.92B
| $316K | ﹤0.01% |
+12,740
| New | +$352K |
|
1799
Alector
ALEC
$169M
| $314K | ﹤0.01% |
+15,190
| New | +$342K |
|
1800
RE/MAX Holdings
RMAX
$206M
| $314K | ﹤0.01% |
10,283
-15,320
| -60% | -$468K |
|
Similar funds
SCP
Ensign Peak Advisors's Q4 2021 Portfolio in Review
As of Q4 2021, Ensign Peak Advisors held 2,277 positions worth $52.3B, up 9% from $48B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Ensign Peak Advisors's Q4 2021 filing shows 427 new, 521 increased, 1,052 reduced and 79 closed positions. Its largest new stake was ironSource Ltd.: 13,801,563 shares worth $107M. The largest sale was AT&T, an estimated $247M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q4 2021 buy was ironSource Ltd.: 13,801,563 shares worth $107M.
- Ensign Peak Advisors added most to Tesla in Q4 2021, an estimated $119M increase.
- Ensign Peak Advisors's biggest Q4 2021 reduction was AT&T, cutting an estimated $247M.
- Ensign Peak Advisors fully exited Acceleron Pharma in Q4 2021, selling an estimated $21.5M.
- Ensign Peak Advisors's ten largest holdings make up 26% of its $52.3B portfolio in Q4 2021.
- Ensign Peak Advisors opened 427 new positions and closed 79 in Q4 2021.
- Ensign Peak Advisors's portfolio value rose 9% quarter-over-quarter to $52.3B.
Based on Ensign Peak Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.